Skip to content

Delirium Incidence and Indwelling Urinary CathEterization After Acute Stroke

Delirium Incidence and Indwelling Urinary CathEterization After Acute Stroke

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07264244
Acronym
DICES
Enrollment
50
Registered
2025-12-04
Start date
2021-04-01
Completion date
2023-03-31
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Delirium

Brief summary

The main goal of this study is to identify indwelling urinary catheterization (IUC) as a predictive factor of the development of delirium in male acute stroke patients.

Detailed description

The main goal of this study is to identify indwelling urinary catheterization (IUC) as a predictive factor of the development of delirium in male acute stroke patients. With a prospective randomized-controlled interventional study design it aims to provide reliable evidence to effectively reduce delirium as well as secondary complications after IUC in critically ill patients. Until now, male, severely affected acute stroke patients regularly receive IUC for recanalization therapy or to balance fluid intake. Complications might be urinary infections, agitation and accidental removal by the patient himself with urinary bleeding. We ought to investigate if early removal of the IUC after recanalization therapy and replacement with either a condom catheter or a diaper might reduce complications after catheterization and hereby reduce delirium. As a secondary outcome we would like to explore other options besides indwelling urinary catheterization for balancing the fluid in- and output.

Interventions

DEVICEcondom catheter

The subjects will be randomly assigned to one of two groups. The subjects in the control group will receive as part of our ongoing clinical routine an IUC at the time of admission. For IUC a well established standard operating procedure in our clinic will be followed (https://vswroxtra01.ukt.ad.local/Roxtra/index.aspx: Legen eines transurethralen Blasenkatheters (BLK). The intervention group will be provided a condom catheter. If necessary, the ladder will be assisted with a urine bottle or a toilet chair

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

outcome assessor is masked for intervention

Intervention model description

randomised open label trial

Eligibility

Sex/Gender
MALE
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion Criteria * Male gender * Age ≥ 70 years * Treated with recanalization therapy and therefore receiving an IUC * Patient is able to provide written informed consent. If patient is aphasic and not in a position to provide written informed consent after the stroke, a relative or a legal guardian can provide information of the presumed will of the patient. Inclusion of this patient is possible if the patient will give basic informed consent as soon as he is able to and after a maximum of seven days after enrollment. As delirium is associated with stroke severity it is necessary to include these patients, otherwise the incidence of delirium will be too low.

Exclusion criteria

* Delirium at admission * Need for mechanical ventilation \> 48h * Presence of an IUC before admission

Design outcomes

Primary

MeasureTime frameDescription
Delirium10 days after admissionThe primary outcome will be the development of delirium within 10 days after admission. Secondary outcomes will be * Length of stay on NICU / stroke unit * Development of UTI * Development of neurological bladder dysfunction * Pleura effusions and/or ankle edema

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026